Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Acquisitions (2022 - 2025)

Historic Acquisitions for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Q2 2025 value amounting to $362000.0.

  • Maravai Lifesciences Holdings' Acquisitions changed N/A to $362000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $19.0 million, marking a year-over-year change of. This contributed to the annual value of $69.6 million for FY2023, which is 7086.57% down from last year.
  • Maravai Lifesciences Holdings' Acquisitions amounted to $362000.0 in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Acquisitions peaked at $238.8 million during Q1 2022, and registered a low of -$109000.0 during Q2 2023.
  • For the 3-year period, Maravai Lifesciences Holdings' Acquisitions averaged around $54.6 million, with its median value being $9.5 million (2025).
  • The largest annual percentage gain for Maravai Lifesciences Holdings' Acquisitions in the last 5 years was 7080.38% (2023), contrasted with its biggest fall of 7080.38% (2023).
  • Maravai Lifesciences Holdings' Acquisitions (Quarter) stood at $133000.0 in 2022, then plummeted by 181.95% to -$109000.0 in 2023, then soared by 432.11% to $362000.0 in 2025.
  • Its last three reported values are $362000.0 in Q2 2025, $18.6 million for Q1 2025, and -$109000.0 during Q2 2023.